Van Beek Jeroen B

Chief Commercial Officer

1 company

Excellent

Trades Analyzed

12M Win Rate

95.8%

Avg 3M Return

+13.1%

Avg 12M Return

+57.9%

Van Beek Jeroen B is a Chief Commercial Officer at Kalaris Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 25 sells.

Estimated insider holdings value: $1.5M based on current market prices.

Holdings by Company

KLRSNov 16, 2022

Current Shares333.7K

Value$1.47M

Net Activity-275,170

Bought: 3.0KSold: 278.2K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 2, 2022	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	516	$9.01	$4,651.38	-0.1%	-56.9%	-32.6%
Feb 16, 2022	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	15,322	$8.32	$127,525.01	-3.8%	-46.2%	-27.7%
Jan 20, 2022	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	4,656	$8.75	$40,752.11	-1.2%	-26.4%	-38.2%
Dec 2, 2021	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	514	$17.06	$8,770.23	-0.1%	-50.4%	-57.1%
Nov 16, 2021	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	15,203	$21.13	$321,262.19	-3.6%	-60.1%	-64.7%
Oct 1, 2021	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	16,584	$25.14	$416,905.70	-1.3%	-48.0%	-69.6%
Sep 17, 2021	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	53,051	$26.57	$1,409,645.64	-1.6%	-39.4%	-66.0%
Mar 1, 2021	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	5,932	$38.78	$230,033.50	-0.6%	-	-
Feb 23, 2021	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	9,083	$41.46	$376,620.95	-0.4%	-	-
Feb 18, 2021	KLRS Kalaris Therapeutics, Inc.	Chief Commercial Officer	Sell	2,085	$40.67	$84,786.79	-0.1%	-	-